2021-2025 POC Diagnostic Testing Market: Unmet Needs, Supplier Shares and Strategies, Segment Volume and Sales Forecasts for 300 Tests, Emerging Technologies and Trends, Instrumentation Pipeline, Growth Opportunities
This new 1,230-page report from LeadingMarketResearch.com contains 343 tables, and provides a comprehensive analysis of the 10 major POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies.
The report is available by section, and can be customized to specific information needs and budget.
Rationale
The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.
Market Segmentation Analysis
Sales and market shares of major reagent and instrument suppliers.
Current and Emerging Products
Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.
Strategic Recommendations
This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and LeadingMarketResearch.com's proprietary data files.
Contains 1,230 pages and 343 tables
The report is available by section, and can be customized to specific information needs and budget.
Rationale
The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.
Market Segmentation Analysis
- Review of the 10 major POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.
- Five-year test volume and reagent sales forecasts for over 300 chemistry, immunodiagnostic, microbiology, hematology and coagulation procedures by market segment:
- Home/Personal Testing
- Physician Offices/Group Practices
- Emergency Rooms
- Operating/Recovery Suites
- ICUs/CCU
- Cancer Clinics
- Ambulatory Care Centers
- Surgery Centers
- Nursing Homes
- Birth Centers and by test category:
- Routine and Special Chemistry
- Microbiology/Infectious Diseases
- Hematology
- Flow Cytometry
- Coagulation
- Immunoproteins
- Drugs of Abuse
- TDM
- Endocrine Function
- Tumor Markers
Sales and market shares of major reagent and instrument suppliers.
Current and Emerging Products
- Analysis of over 130 diagnostic procedures.
- Review of leading chemistry, immunoassay, hematology and coagulation analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices.
- Emerging technologies and their applications for POC testing.
- Comprehensive listings of companies developing or marketing POC diagnostic technologies and products, by test.
Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.
Strategic Recommendations
- Specific opportunities for new POC instruments and reagent systems with potentially significant market appeal during the next five years.
- Design criteria for POC testing products.
- Alternative business expansion strategies.
- Potential market entry barriers and risks.
This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and LeadingMarketResearch.com's proprietary data files.
Contains 1,230 pages and 343 tables
INTRODUCTION
EXECUTIVE SUMMARY
RATIONALE FOR TESTING DECENTRALIZATION
&nbsop;&nbsop;1. Overview
&nbsop;&nbsop;2. Regulatory Trends
&nbsop;&nbsop;3. Economic Trends
&nbsop;&nbsop;4. Demographic Trends
&nbsop;&nbsop;5. Technological Trends
&nbsop;&nbsop;6. Social Trends
&nbsop;&nbsop;7. Quality of Care
&nbsop;&nbsop;8. Defensive Medicine
&nbsop;&nbsop;9. Quality Control Issues
WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Routine Chemistry Tests
&nbsop;&nbsop;1. Albumin
&nbsop;&nbsop;2. Alkaline Phosphatase
&nbsop;&nbsop;3. ALT/SGPT
&nbsop;&nbsop;4. Ammonia
&nbsop;&nbsop;5. Amylase
&nbsop;&nbsop;6. AST/SGOT
&nbsop;&nbsop;7. Bilirubin
&nbsop;&nbsop;8. Blood Gases
&nbsop;&nbsop;9. Blood Urea Nitrogen (BUN)
&nbsop;&nbsop;10. Calcium
&nbsop;&nbsop;11. Cholesterol
&nbsop;&nbsop;12. Cholinesterase
&nbsop;&nbsop;13. Creatinine
&nbsop;&nbsop;14. Electrolytes
&nbsop;&nbsop;&nbsop;&nbsop;a. Carbon Dioxide/Bicarbonate
&nbsop;&nbsop;&nbsop;&nbsop;b. Chloride
&nbsop;&nbsop;&nbsop;&nbsop;c. Potassium
&nbsop;&nbsop;&nbsop;&nbsop;d. Sodium
&nbsop;&nbsop;15. Ferritin
&nbsop;&nbsop;16. Follate/Folic Acid
&nbsop;&nbsop;17. Fructosamine
&nbsop;&nbsop;18. Gamma-Glutamyl Transpeptidase (GGT)
&nbsop;&nbsop;19. Glucose
&nbsop;&nbsop;20. High Density Lipoprotein (HDL)
&nbsop;&nbsop;21. Iron
&nbsop;&nbsop;22. Lactate Dehydrogenase (LDH)
&nbsop;&nbsop;23. Magnesium
&nbsop;&nbsop;24. Phosphorus
&nbsop;&nbsop;25. Protein
&nbsop;&nbsop;26. Triglycerides
&nbsop;&nbsop;27. Troponin
&nbsop;&nbsop;28. Uric Acid
&nbsop;&nbsop;29. Urinalysis
&nbsop;&nbsop;30. Vitamin B12
Infectious Disease Tests
&nbsop;&nbsop;1. AIDS
&nbsop;&nbsop;2. Adenovirus
&nbsop;&nbsop;3. Campylobacter
&nbsop;&nbsop;4. Candida
&nbsop;&nbsop;5. Chlamydia
&nbsop;&nbsop;6. Clostridium Difficile
&nbsop;&nbsop;7. Cytomegalovirus
&nbsop;&nbsop;8. Enteroviruses
&nbsop;&nbsop;9. Epstein-Barr Virus
&nbsop;&nbsop;10. Gonorrhea
&nbsop;&nbsop;11. Helicobacter Pylori
&nbsop;&nbsop;12. Hepatitis
&nbsop;&nbsop;&nbsop;&nbsop;a. Hepatitis A
&nbsop;&nbsop;&nbsop;&nbsop;b. Hepatitis B
&nbsop;&nbsop;&nbsop;&nbsop;c. Hepatitis C
&nbsop;&nbsop;&nbsop;&nbsop;d. Hepatitis D
&nbsop;&nbsop;13. Herpes Simplex Virus
&nbsop;&nbsop;14. Human Herpes Virus-6 (HHV-6)
&nbsop;&nbsop;15. Influenza Viruses
&nbsop;&nbsop;16. Legionella
&nbsop;&nbsop;17. Lyme Disease
&nbsop;&nbsop;18. Measles (Rubeola)
&nbsop;&nbsop;19. Meningitis
&nbsop;&nbsop;20. Mononucleosis
&nbsop;&nbsop;21. Mumps
&nbsop;&nbsop;22. Mycoplasma
&nbsop;&nbsop;23. Papillomaviruses
&nbsop;&nbsop;24. Pneumonia
&nbsop;&nbsop;25. Respiratory Syncytial Virus (RSV)
&nbsop;&nbsop;26. Rheumatoid Arthritis
&nbsop;&nbsop;27. Rotavirus (Reovirus)
&nbsop;&nbsop;28. Rubella (German Measles)
&nbsop;&nbsop;29. Salmonellosis
&nbsop;&nbsop;30. Shigellosis
&nbsop;&nbsop;31. Staphylococcus Aureus
&nbsop;&nbsop;32. Streptococci
&nbsop;&nbsop;33. Syphilis
Tumor Markers
&nbsop;&nbsop;1. Alpha-Fetoprotein (AFP)
&nbsop;&nbsop;2. Carcinoembrionic Antigen (CEA)
&nbsop;&nbsop;3. Occult Blood
&nbsop;&nbsop;4. Prostatic Acid Phosphatase (PAP)
&nbsop;&nbsop;5. Prostate-Specific Antigen (PSA)
Major Routine and Special Hematology Tests
&nbsop;&nbsop;1. CBC Analysis
&nbsop;&nbsop;&nbsop;&nbsop;a. Hemoglobin Concentration
&nbsop;&nbsop;&nbsop;&nbsop;b. Hematocrit Determination
&nbsop;&nbsop;&nbsop;&nbsop;c. Red Blood Cell Count
&nbsop;&nbsop;&nbsop;&nbsop;d. Platelets
Endocrine Function Tests
&nbsop;&nbsop;1. Cortisol
&nbsop;&nbsop;2. Follicle-Stimulating Hormone (FSH)
&nbsop;&nbsop;3. Gastrin
&nbsop;&nbsop;4. Human Chorionic Gonadotropin (HCG)
&nbsop;&nbsop;5. LH
&nbsop;&nbsop;6. Prolactin
&nbsop;&nbsop;7. T3
&nbsop;&nbsop;8. T3 Uptake
&nbsop;&nbsop;9. Free T3
&nbsop;&nbsop;10. Thyroxine (T4)
&nbsop;&nbsop;11. Free T4
&nbsop;&nbsop;12. TBG
&nbsop;&nbsop;13. TSH
Therapeutic Drug Monitoring (TDM)
&nbsop;&nbsop;1. Overview
&nbsop;&nbsop;2. Carbamazepine
&nbsop;&nbsop;3. Digoxin
&nbsop;&nbsop;4. Gentamicin
&nbsop;&nbsop;5. Lidocaine
&nbsop;&nbsop;6. Lithium
&nbsop;&nbsop;7. Phenytoin/Dilantin
&nbsop;&nbsop;8. Procainamide
&nbsop;&nbsop;9. Quinidine
&nbsop;&nbsop;10. Theophylline
&nbsop;&nbsop;11. Valproic Acid Coagulation Tests
&nbsop;&nbsop;1. Introduction
&nbsop;&nbsop;2. Activated Partial Thromboplastin Time (APTT)
&nbsop;&nbsop;3. Alpha-2 Antiplasmin
&nbsop;&nbsop;4. Antithrombin III
&nbsop;&nbsop;5. Bleeding Time
&nbsop;&nbsop;6. D-Dimer
&nbsop;&nbsop;7. Factor VIII
&nbsop;&nbsop;8. Fibrin Degradation Products
&nbsop;&nbsop;9. Fibrinogen
&nbsop;&nbsop;10. Heparin
&nbsop;&nbsop;11. Proteins C and S
&nbsop;&nbsop;12. Prothrombin Time (PT)
&nbsop;&nbsop;13. Thrombin Time
Immunoprotein Tests
&nbsop;&nbsop;1. CRP
&nbsop;&nbsop;2. Immunoglobulins
Drugs of Abuse
&nbsop;&nbsop;1. Overview
&nbsop;&nbsop;2. Test Methodologies
&nbsop;&nbsop;3. Amphetamines
&nbsop;&nbsop;4. Barbiturates
&nbsop;&nbsop;5. Benzodiazepines
&nbsop;&nbsop;6. Cannabinoids/Marijuana
&nbsop;&nbsop;7. Cocaine
&nbsop;&nbsop;8. Lysergic Acid Diethylamide (LSD)
&nbsop;&nbsop;9. Methadone
&nbsop;&nbsop;10. Methaqualone
&nbsop;&nbsop;11. Opiates
&nbsop;&nbsop;12. Phencyclidine
Instrumentation
&nbsop;&nbsop;1. Chemistry Analyzers
&nbsop;&nbsop;2. Hematology Analyzers
&nbsop;&nbsop;3. Coagulation Analyzers
Current and Emerging Technologies
&nbsop;&nbsop;1. Monoclonal Antibodies
&nbsop;&nbsop;2. Immunoassays
&nbsop;&nbsop;&nbsop;&nbsop;a. Technological Principle
&nbsop;&nbsop;&nbsop;&nbsop;b. Enzyme Immunoassays (EIA)
Overview
ELISA
Dot Immunobinding Assays
Capillary Immunoassays
Particle-Membrane Capture Immunoassay
Enzyme Amplification
&nbsop;&nbsop;&nbsop;&nbsop;c. Fluorescent Immunoassays
Fluorescent Polarization
Time-Resolved Pulse Fluorescence
&nbsop;&nbsop;&nbsop;&nbsop;d. Luminescence
Chemiluminescence
Bioluminescence
&nbsop;&nbsop;&nbsop;&nbsop;e. Latex Agglutination
&nbsop;&nbsop;&nbsop;&nbsop;f. Immunoprecipitation
&nbsop;&nbsop;3. Dry Chemistry
&nbsop;&nbsop;4. Biosensors
&nbsop;&nbsop;5. IT and Automation
&nbsop;&nbsop;6. Molecular Diagnostics
&nbsop;&nbsop;&nbsop;&nbsop;a. Technology Overview
&nbsop;&nbsop;&nbsop;&nbsop;b. Amplification Methods
Polymerase Chain Reaction
Ligase Chain Reaction
Branched DNA
Q-Beta Replicase
Strand Displacement Activation
Self-Sustained Sequence Replicase
Worldwide Business Environment
U.S.A.
A. Market Overview
&nbsop;&nbsop;1. Business Environment
&nbsop;&nbsop;&nbsop;&nbsop;a. Health Care Expenditures
&nbsop;&nbsop;&nbsop;&nbsop;b. Cost Consciousness
&nbsop;&nbsop;&nbsop;&nbsop;c. Reimbursement
&nbsop;&nbsop;&nbsop;&nbsop;d. Industry Consolidation
&nbsop;&nbsop;&nbsop;&nbsop;e. Managed Care
PPO
HMO
&nbsop;&nbsop;&nbsop;&nbsop;f. Hospitals
&nbsop;&nbsop;&nbsop;&nbsop;g. Admissions
&nbsop;&nbsop;&nbsop;&nbsop;h. Length of Stay
&nbsop;&nbsop;&nbsop;&nbsop;i. Industry Diversification
&nbsop;&nbsop;&nbsop;&nbsop;j. Physician Demographics
&nbsop;&nbsop;&nbsop;&nbsop;k. Aging Population
More Chronic Illness
Disease Incidence
Susceptibility to latrogenesis
Multiple Illnesses Cases
&nbsop;&nbsop;&nbsop;&nbsop;l. Laboratory Regulations
&nbsop;&nbsop;2. Market Structure
&nbsop;&nbsop;&nbsop;&nbsop;a. Hospitals
&nbsop;&nbsop;&nbsop;&nbsop;b. Commercial/Private Laboratories
B. Personal Testing
&nbsop;&nbsop;1. Glucose Monitoring Market and Technology Overview
Invasive Testing
Non-Invasive Testing
Genetic Testing
&nbsop;&nbsop;2. Pregnancy Tests
&nbsop;&nbsop;3. Occult Blood Tests
&nbsop;&nbsop;4. Market Size and Growth
C. Physician Offices/Group Practices
&nbsop;&nbsop;1. Market Summary
&nbsop;&nbsop;2. Market Structure
&nbsop;&nbsop;3. Test Volume and Sales Forecasts
D. Ancillary Hospital Locations
&nbsop;&nbsop;1. Introduction
&nbsop;&nbsop;&nbsop;&nbsop;a. Emergency Departments
&nbsop;&nbsop;&nbsop;&nbsop;b. Operating Suites
&nbsop;&nbsop;&nbsop;&nbsop;c. Intensive Care Units
&nbsop;&nbsop;2. Emergency Departments
&nbsop;&nbsop;&nbsop;&nbsop;a. Market Summary
&nbsop;&nbsop;&nbsop;&nbsop;b. Test volume and Sales Forecasts
&nbsop;&nbsop;3. Operating and Recovery Suites
&nbsop;&nbsop;&nbsop;&nbsop;a. Market Summary
&nbsop;&nbsop;&nbsop;&nbsop;b. Test Volume and Sales Forecasts
&nbsop;&nbsop;4. ICUs/CCUs
&nbsop;&nbsop;&nbsop;&nbsop;a. Market Summary
&nbsop;&nbsop;&nbsop;&nbsop;b. Test Volume and Sales Forecasts
E. Cancer Clinics
&nbsop;&nbsop;1. Introduction
&nbsop;&nbsop;2. Market Summary
&nbsop;&nbsop;3. Test Volume and Sales Forecasts
F. Ambulatory Care Centers
&nbsop;&nbsop;1. Introduction
&nbsop;&nbsop;2. Market Summary
&nbsop;&nbsop;3. Market Structure
&nbsop;&nbsop;4. Test Volume and Sales Forecasts
G. Surgery Centers
&nbsop;&nbsop;1. Introduction
&nbsop;&nbsop;2. Market Summary
&nbsop;&nbsop;3. Market Structure
&nbsop;&nbsop;4. Test Volume and Sales Forecasts
H. Nursing Homes
&nbsop;&nbsop;1. Introduction
&nbsop;&nbsop;2. Market Summary
&nbsop;&nbsop;3. Market Structure
&nbsop;&nbsop;4. Test Volume and Sales Forecasts
I. BIRTH CENTERS
&nbsop;&nbsop;1. Introduction
&nbsop;&nbsop;2. Market Summary
&nbsop;&nbsop;3. Market Structure
&nbsop;&nbsop;4. Test Volume and Sales Forecasts
J. Major Suppliers’ Instrument Placements, Installed Base, Consumables Sales and Market Shares
GERMANY
A. Market Overview
B. Market Structure
C. Market Summary
D. Test Volume and Sales Forecasts
E. Major Suppliers’ Instrument Placements, Installed Base, Consumables Sales and Market Shares
SPAIN
A. Business Environment
B. Market Structure
C. Market Summary
D. Test Volume and Sales Forecasts
E. Major Suppliers’ Instrument Placements, Installed Base, Consumables Sales and Market Shares
MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Routine and Special Chemistry
B. Microbiology/Infectious Diseases
C. Hematology and Flow Cytometry
D. Coagulation
DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
&nbsop;&nbsop;1. Marketing Approaches
&nbsop;&nbsop;2. Product complexity
&nbsop;&nbsop;3. Customer Preference
&nbsop;&nbsop;4. Established Suppliers
&nbsop;&nbsop;5. Emerging Suppliers
&nbsop;&nbsop;6. Major Types of Distributors
&nbsop;&nbsop;7. Market Segmentation
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
COMPANY PROFILE
Abbott
Agilent Technologies
Beckman Coulter/Cepheid/Danaher
Becton Dickinson
Bio/Data
bioMerieux
Bio-Rad
Chrono-Log
Corgenix
Decode Genetics
Diagnostica Stago
Diamedix
Diasorin
Eiken Chemical
EKF Diagnostics
Fujirebio
Grifols
Helena Laboratories
Hologic/Gen-Probe
Horiba
Instrumentation Laboratory
Kyowa Medex
Leica Biosystems/Kreatech
Lonza
Nihon Kohden
Ortho-Clinical Diagnostics/Carlyle Group
Polymedco
Qiagen
Roche
SDIX
Sekisui Diagnostics
Sequenom
Siemens Healthineers
Sienco
Sysmex
Takara Bio
Thermo Fisher
Tosoh
Wako
EXECUTIVE SUMMARY
RATIONALE FOR TESTING DECENTRALIZATION
&nbsop;&nbsop;1. Overview
&nbsop;&nbsop;2. Regulatory Trends
&nbsop;&nbsop;3. Economic Trends
&nbsop;&nbsop;4. Demographic Trends
&nbsop;&nbsop;5. Technological Trends
&nbsop;&nbsop;6. Social Trends
&nbsop;&nbsop;7. Quality of Care
&nbsop;&nbsop;8. Defensive Medicine
&nbsop;&nbsop;9. Quality Control Issues
WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Routine Chemistry Tests
&nbsop;&nbsop;1. Albumin
&nbsop;&nbsop;2. Alkaline Phosphatase
&nbsop;&nbsop;3. ALT/SGPT
&nbsop;&nbsop;4. Ammonia
&nbsop;&nbsop;5. Amylase
&nbsop;&nbsop;6. AST/SGOT
&nbsop;&nbsop;7. Bilirubin
&nbsop;&nbsop;8. Blood Gases
&nbsop;&nbsop;9. Blood Urea Nitrogen (BUN)
&nbsop;&nbsop;10. Calcium
&nbsop;&nbsop;11. Cholesterol
&nbsop;&nbsop;12. Cholinesterase
&nbsop;&nbsop;13. Creatinine
&nbsop;&nbsop;14. Electrolytes
&nbsop;&nbsop;&nbsop;&nbsop;a. Carbon Dioxide/Bicarbonate
&nbsop;&nbsop;&nbsop;&nbsop;b. Chloride
&nbsop;&nbsop;&nbsop;&nbsop;c. Potassium
&nbsop;&nbsop;&nbsop;&nbsop;d. Sodium
&nbsop;&nbsop;15. Ferritin
&nbsop;&nbsop;16. Follate/Folic Acid
&nbsop;&nbsop;17. Fructosamine
&nbsop;&nbsop;18. Gamma-Glutamyl Transpeptidase (GGT)
&nbsop;&nbsop;19. Glucose
&nbsop;&nbsop;20. High Density Lipoprotein (HDL)
&nbsop;&nbsop;21. Iron
&nbsop;&nbsop;22. Lactate Dehydrogenase (LDH)
&nbsop;&nbsop;23. Magnesium
&nbsop;&nbsop;24. Phosphorus
&nbsop;&nbsop;25. Protein
&nbsop;&nbsop;26. Triglycerides
&nbsop;&nbsop;27. Troponin
&nbsop;&nbsop;28. Uric Acid
&nbsop;&nbsop;29. Urinalysis
&nbsop;&nbsop;30. Vitamin B12
Infectious Disease Tests
&nbsop;&nbsop;1. AIDS
&nbsop;&nbsop;2. Adenovirus
&nbsop;&nbsop;3. Campylobacter
&nbsop;&nbsop;4. Candida
&nbsop;&nbsop;5. Chlamydia
&nbsop;&nbsop;6. Clostridium Difficile
&nbsop;&nbsop;7. Cytomegalovirus
&nbsop;&nbsop;8. Enteroviruses
&nbsop;&nbsop;9. Epstein-Barr Virus
&nbsop;&nbsop;10. Gonorrhea
&nbsop;&nbsop;11. Helicobacter Pylori
&nbsop;&nbsop;12. Hepatitis
&nbsop;&nbsop;&nbsop;&nbsop;a. Hepatitis A
&nbsop;&nbsop;&nbsop;&nbsop;b. Hepatitis B
&nbsop;&nbsop;&nbsop;&nbsop;c. Hepatitis C
&nbsop;&nbsop;&nbsop;&nbsop;d. Hepatitis D
&nbsop;&nbsop;13. Herpes Simplex Virus
&nbsop;&nbsop;14. Human Herpes Virus-6 (HHV-6)
&nbsop;&nbsop;15. Influenza Viruses
&nbsop;&nbsop;16. Legionella
&nbsop;&nbsop;17. Lyme Disease
&nbsop;&nbsop;18. Measles (Rubeola)
&nbsop;&nbsop;19. Meningitis
&nbsop;&nbsop;20. Mononucleosis
&nbsop;&nbsop;21. Mumps
&nbsop;&nbsop;22. Mycoplasma
&nbsop;&nbsop;23. Papillomaviruses
&nbsop;&nbsop;24. Pneumonia
&nbsop;&nbsop;25. Respiratory Syncytial Virus (RSV)
&nbsop;&nbsop;26. Rheumatoid Arthritis
&nbsop;&nbsop;27. Rotavirus (Reovirus)
&nbsop;&nbsop;28. Rubella (German Measles)
&nbsop;&nbsop;29. Salmonellosis
&nbsop;&nbsop;30. Shigellosis
&nbsop;&nbsop;31. Staphylococcus Aureus
&nbsop;&nbsop;32. Streptococci
&nbsop;&nbsop;33. Syphilis
Tumor Markers
&nbsop;&nbsop;1. Alpha-Fetoprotein (AFP)
&nbsop;&nbsop;2. Carcinoembrionic Antigen (CEA)
&nbsop;&nbsop;3. Occult Blood
&nbsop;&nbsop;4. Prostatic Acid Phosphatase (PAP)
&nbsop;&nbsop;5. Prostate-Specific Antigen (PSA)
Major Routine and Special Hematology Tests
&nbsop;&nbsop;1. CBC Analysis
&nbsop;&nbsop;&nbsop;&nbsop;a. Hemoglobin Concentration
&nbsop;&nbsop;&nbsop;&nbsop;b. Hematocrit Determination
&nbsop;&nbsop;&nbsop;&nbsop;c. Red Blood Cell Count
&nbsop;&nbsop;&nbsop;&nbsop;d. Platelets
Endocrine Function Tests
&nbsop;&nbsop;1. Cortisol
&nbsop;&nbsop;2. Follicle-Stimulating Hormone (FSH)
&nbsop;&nbsop;3. Gastrin
&nbsop;&nbsop;4. Human Chorionic Gonadotropin (HCG)
&nbsop;&nbsop;5. LH
&nbsop;&nbsop;6. Prolactin
&nbsop;&nbsop;7. T3
&nbsop;&nbsop;8. T3 Uptake
&nbsop;&nbsop;9. Free T3
&nbsop;&nbsop;10. Thyroxine (T4)
&nbsop;&nbsop;11. Free T4
&nbsop;&nbsop;12. TBG
&nbsop;&nbsop;13. TSH
Therapeutic Drug Monitoring (TDM)
&nbsop;&nbsop;1. Overview
&nbsop;&nbsop;2. Carbamazepine
&nbsop;&nbsop;3. Digoxin
&nbsop;&nbsop;4. Gentamicin
&nbsop;&nbsop;5. Lidocaine
&nbsop;&nbsop;6. Lithium
&nbsop;&nbsop;7. Phenytoin/Dilantin
&nbsop;&nbsop;8. Procainamide
&nbsop;&nbsop;9. Quinidine
&nbsop;&nbsop;10. Theophylline
&nbsop;&nbsop;11. Valproic Acid Coagulation Tests
&nbsop;&nbsop;1. Introduction
&nbsop;&nbsop;2. Activated Partial Thromboplastin Time (APTT)
&nbsop;&nbsop;3. Alpha-2 Antiplasmin
&nbsop;&nbsop;4. Antithrombin III
&nbsop;&nbsop;5. Bleeding Time
&nbsop;&nbsop;6. D-Dimer
&nbsop;&nbsop;7. Factor VIII
&nbsop;&nbsop;8. Fibrin Degradation Products
&nbsop;&nbsop;9. Fibrinogen
&nbsop;&nbsop;10. Heparin
&nbsop;&nbsop;11. Proteins C and S
&nbsop;&nbsop;12. Prothrombin Time (PT)
&nbsop;&nbsop;13. Thrombin Time
Immunoprotein Tests
&nbsop;&nbsop;1. CRP
&nbsop;&nbsop;2. Immunoglobulins
Drugs of Abuse
&nbsop;&nbsop;1. Overview
&nbsop;&nbsop;2. Test Methodologies
&nbsop;&nbsop;3. Amphetamines
&nbsop;&nbsop;4. Barbiturates
&nbsop;&nbsop;5. Benzodiazepines
&nbsop;&nbsop;6. Cannabinoids/Marijuana
&nbsop;&nbsop;7. Cocaine
&nbsop;&nbsop;8. Lysergic Acid Diethylamide (LSD)
&nbsop;&nbsop;9. Methadone
&nbsop;&nbsop;10. Methaqualone
&nbsop;&nbsop;11. Opiates
&nbsop;&nbsop;12. Phencyclidine
Instrumentation
&nbsop;&nbsop;1. Chemistry Analyzers
&nbsop;&nbsop;2. Hematology Analyzers
&nbsop;&nbsop;3. Coagulation Analyzers
Current and Emerging Technologies
&nbsop;&nbsop;1. Monoclonal Antibodies
&nbsop;&nbsop;2. Immunoassays
&nbsop;&nbsop;&nbsop;&nbsop;a. Technological Principle
&nbsop;&nbsop;&nbsop;&nbsop;b. Enzyme Immunoassays (EIA)
Overview
ELISA
Dot Immunobinding Assays
Capillary Immunoassays
Particle-Membrane Capture Immunoassay
Enzyme Amplification
&nbsop;&nbsop;&nbsop;&nbsop;c. Fluorescent Immunoassays
Fluorescent Polarization
Time-Resolved Pulse Fluorescence
&nbsop;&nbsop;&nbsop;&nbsop;d. Luminescence
Chemiluminescence
Bioluminescence
&nbsop;&nbsop;&nbsop;&nbsop;e. Latex Agglutination
&nbsop;&nbsop;&nbsop;&nbsop;f. Immunoprecipitation
&nbsop;&nbsop;3. Dry Chemistry
&nbsop;&nbsop;4. Biosensors
&nbsop;&nbsop;5. IT and Automation
&nbsop;&nbsop;6. Molecular Diagnostics
&nbsop;&nbsop;&nbsop;&nbsop;a. Technology Overview
&nbsop;&nbsop;&nbsop;&nbsop;b. Amplification Methods
Polymerase Chain Reaction
Ligase Chain Reaction
Branched DNA
Q-Beta Replicase
Strand Displacement Activation
Self-Sustained Sequence Replicase
Worldwide Business Environment
U.S.A.
A. Market Overview
&nbsop;&nbsop;1. Business Environment
&nbsop;&nbsop;&nbsop;&nbsop;a. Health Care Expenditures
&nbsop;&nbsop;&nbsop;&nbsop;b. Cost Consciousness
&nbsop;&nbsop;&nbsop;&nbsop;c. Reimbursement
&nbsop;&nbsop;&nbsop;&nbsop;d. Industry Consolidation
&nbsop;&nbsop;&nbsop;&nbsop;e. Managed Care
PPO
HMO
&nbsop;&nbsop;&nbsop;&nbsop;f. Hospitals
&nbsop;&nbsop;&nbsop;&nbsop;g. Admissions
&nbsop;&nbsop;&nbsop;&nbsop;h. Length of Stay
&nbsop;&nbsop;&nbsop;&nbsop;i. Industry Diversification
&nbsop;&nbsop;&nbsop;&nbsop;j. Physician Demographics
&nbsop;&nbsop;&nbsop;&nbsop;k. Aging Population
More Chronic Illness
Disease Incidence
Susceptibility to latrogenesis
Multiple Illnesses Cases
&nbsop;&nbsop;&nbsop;&nbsop;l. Laboratory Regulations
&nbsop;&nbsop;2. Market Structure
&nbsop;&nbsop;&nbsop;&nbsop;a. Hospitals
&nbsop;&nbsop;&nbsop;&nbsop;b. Commercial/Private Laboratories
B. Personal Testing
&nbsop;&nbsop;1. Glucose Monitoring Market and Technology Overview
Invasive Testing
Non-Invasive Testing
Genetic Testing
&nbsop;&nbsop;2. Pregnancy Tests
&nbsop;&nbsop;3. Occult Blood Tests
&nbsop;&nbsop;4. Market Size and Growth
C. Physician Offices/Group Practices
&nbsop;&nbsop;1. Market Summary
&nbsop;&nbsop;2. Market Structure
&nbsop;&nbsop;3. Test Volume and Sales Forecasts
D. Ancillary Hospital Locations
&nbsop;&nbsop;1. Introduction
&nbsop;&nbsop;&nbsop;&nbsop;a. Emergency Departments
&nbsop;&nbsop;&nbsop;&nbsop;b. Operating Suites
&nbsop;&nbsop;&nbsop;&nbsop;c. Intensive Care Units
&nbsop;&nbsop;2. Emergency Departments
&nbsop;&nbsop;&nbsop;&nbsop;a. Market Summary
&nbsop;&nbsop;&nbsop;&nbsop;b. Test volume and Sales Forecasts
&nbsop;&nbsop;3. Operating and Recovery Suites
&nbsop;&nbsop;&nbsop;&nbsop;a. Market Summary
&nbsop;&nbsop;&nbsop;&nbsop;b. Test Volume and Sales Forecasts
&nbsop;&nbsop;4. ICUs/CCUs
&nbsop;&nbsop;&nbsop;&nbsop;a. Market Summary
&nbsop;&nbsop;&nbsop;&nbsop;b. Test Volume and Sales Forecasts
E. Cancer Clinics
&nbsop;&nbsop;1. Introduction
&nbsop;&nbsop;2. Market Summary
&nbsop;&nbsop;3. Test Volume and Sales Forecasts
F. Ambulatory Care Centers
&nbsop;&nbsop;1. Introduction
&nbsop;&nbsop;2. Market Summary
&nbsop;&nbsop;3. Market Structure
&nbsop;&nbsop;4. Test Volume and Sales Forecasts
G. Surgery Centers
&nbsop;&nbsop;1. Introduction
&nbsop;&nbsop;2. Market Summary
&nbsop;&nbsop;3. Market Structure
&nbsop;&nbsop;4. Test Volume and Sales Forecasts
H. Nursing Homes
&nbsop;&nbsop;1. Introduction
&nbsop;&nbsop;2. Market Summary
&nbsop;&nbsop;3. Market Structure
&nbsop;&nbsop;4. Test Volume and Sales Forecasts
I. BIRTH CENTERS
&nbsop;&nbsop;1. Introduction
&nbsop;&nbsop;2. Market Summary
&nbsop;&nbsop;3. Market Structure
&nbsop;&nbsop;4. Test Volume and Sales Forecasts
J. Major Suppliers’ Instrument Placements, Installed Base, Consumables Sales and Market Shares
GERMANY
A. Market Overview
B. Market Structure
C. Market Summary
D. Test Volume and Sales Forecasts
E. Major Suppliers’ Instrument Placements, Installed Base, Consumables Sales and Market Shares
SPAIN
A. Business Environment
B. Market Structure
C. Market Summary
D. Test Volume and Sales Forecasts
E. Major Suppliers’ Instrument Placements, Installed Base, Consumables Sales and Market Shares
MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Routine and Special Chemistry
B. Microbiology/Infectious Diseases
C. Hematology and Flow Cytometry
D. Coagulation
DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
&nbsop;&nbsop;1. Marketing Approaches
&nbsop;&nbsop;2. Product complexity
&nbsop;&nbsop;3. Customer Preference
&nbsop;&nbsop;4. Established Suppliers
&nbsop;&nbsop;5. Emerging Suppliers
&nbsop;&nbsop;6. Major Types of Distributors
&nbsop;&nbsop;7. Market Segmentation
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
COMPANY PROFILE
Abbott
Agilent Technologies
Beckman Coulter/Cepheid/Danaher
Becton Dickinson
Bio/Data
bioMerieux
Bio-Rad
Chrono-Log
Corgenix
Decode Genetics
Diagnostica Stago
Diamedix
Diasorin
Eiken Chemical
EKF Diagnostics
Fujirebio
Grifols
Helena Laboratories
Hologic/Gen-Probe
Horiba
Instrumentation Laboratory
Kyowa Medex
Leica Biosystems/Kreatech
Lonza
Nihon Kohden
Ortho-Clinical Diagnostics/Carlyle Group
Polymedco
Qiagen
Roche
SDIX
Sekisui Diagnostics
Sequenom
Siemens Healthineers
Sienco
Sysmex
Takara Bio
Thermo Fisher
Tosoh
Wako
